Otsuka and Pfizer set consistent standard for stewardship and access plans

Millions of people live without reliable access to effective antibacterial and antifungal products, yet excessive or inappropriate use of these products can render them ineffective. The need to enhance access goes hand in hand with that of ensuring appropriate use to keep medicines working.

Explore further

Get in touch

Back to top |